The ENCyclopedia Of DNA Elements (ENCODE) project is a public research consortium that aims to identify all functional elements of the human genome sequence. The project comprised 1640 data sets, from 147 different cell type and the findings were released in a coordinated set of 34 publications across several journals. The ENCODE publications report that 80.4% of the human genome displays some functionality. These data have important implications for interpreting results from large-scale genetics studies. We reviewed some of the key findings from the ENCODE publications and discuss how they can influence or inform further investigations into the genetic factors contributing to neuropsychiatric disorders.
WHAT IS ENCODE?
The ENCyclopedia Of DNA Elements (ENCODE) project is a public research consortium that aims to identify all functional elements of the human genome sequence (Encode, 2004 Science).The ENCODE pilot phase, published in 2007, 1 targeted 1% of the genome in order to evaluate a set of technologies and analytic techniques that would enable functional elements to be identified. The second phase, termed the technology development phase, aimed to address the shortcomings of the technologies used in the pilot project by developing new, or improving on, laboratory and computational methods for the identification of genomic elements. These functional genomic elements include RNA transcribed regions, protein-coding regions, transcription factor (TF)-binding sites, chromatin structure and DNA methylation sites. The third phase of ENCODE is the production phase, in which the techniques and methods refined in phase II are applied in a comprehensive fashion.
In order to map functional elements across the genome, ENCODE organised a list of human cell and tissue types to be utilised in phase II into three tiers. Tier 1, the set of most comprehensively studied cells, contained GM12878, a B-lymphocyte Epstein-Barr virus immortalised cell line, H1-hESC, a human embryonic stem cell line, and K562, a leukaemia cell line. Tier 2 contained 15 cells or tissues, which included a neuronal cell line. Tier 3 contained a further 336 cell lines or tissue samples. The final data set comprised 1640 data sets, from 147 different cell types.
In September 2012, the ENCODE project released its findings in a coordinated set of 34 publications across several journals. Thirty papers were published by Nature, Genome Biology and Genome Research (which can be accessed via the Nature Encode explorer http://www.nature.com/encode/#/threads), whereas the remaining four were published in BMC Genomics, 2 Science 3,4 and Cell. 5 The broad conclusions of the ENCODE project were that 80.4% of the human genome displays some functionality, be it the encoding of genes, non-coding RNAs or some chromatinassociated event, in at least one cell type. Indeed many of the identified ENCODE elements are involved in the regulation of transcription and translation. These data have been analysed using a variety of methods, in order to address many different questions about evolution, transcriptional regulation and human variation.
CHROMATIN CONFORMATION
Open chromatin is a marker of regulatorily active regions of the genome and can be identified as sites of DNase hypersensitivity (DHSs) mapped by DNase-seq. 6 Approximately 5% of the DHSs identified by ENCODE encompass or lie within 2.5 kb of known transcription start sites (TSS), whereas the remainder were located in distal intronic or intergenic regions. The majority of nonpromoter regulatory elements as well as ENCODE chromatin immunoprecipitation followed by sequencing (ChIP-seq) peaks overlapped with the mapped DHSs, suggesting that DHS peaks were indicators of regulatory active DNA. 7 This map of 'accessible chromatin' provides a baseline for regions of the genome involved in transcriptional control. Flanking these regions of open chromatin are nucleosomes, and post-translational modification of the histone tails at the core of nucleosomes can change the structure of the chromatin, affecting transcription. Quantification of histone modification by ChIP-seq enabled the use of predictive modelling to accurately reflect gene expression status and expression levels. 8 The organisation of chromatin is an important dimension in regulation of transcription, as longrange interactions of enhancer or repressor elements that can be several hundred kilobases or even megabases apart affect gene activation through chromatin folding. 9 Folding interactions were found to be enriched for CCCTC binding factor (CTCF; a TF with many different functions including transcriptional activation and transcriptional repression) binding sites (thought to be involved in regulating three-dimensional chromatin structure), open chromatin and histone marks associated with active functional elements. 10 Correlations between DHSs and distal promoters produced a set of putative distal regulatory elements, up to 500 kb distant from the promoters, 7 which also correlate with regions identified to undergo looping interactions, underpinning their biological significance.
TF-BINDING SITES
Activation of transcription is in part controlled by the binding of TFs to elements present in the promoter, as well as proximally and distally located elements such as enhancers and repressors. 11 Analysis of ChIP-seq data from 117 TFs in five cell lines, revealed six distinct types of genomic regions: active and inactive binding regions, promoter-proximal and gene-distal regulatory modules, and high and low occupancy of transcription-related factors. 12 Predicted binding sites within ChIP-seq peaks were mutagenised to assess their functional impact of reporter assays. Over all the binding sites tested in each cell line, 70% had some impact on function, with higher mean conservation scores and closer proximity to the TSS, than those that did not impact function. 13 Co-association networks of TFs revealed highly cell-type-specific regulatory networks that recapitulated many known regulatory sub-networks in addition to discovering many novel ones.
14 Simultaneous single-nucleotide polymorphism (SNP) discovery and allele-specific bias of TF binding from ChIP-seq data is a novel method for assessing the functional implication of genetic variants in samples that have no prior genotype information. SNPs discovered in this manner showed a strong enrichment for genome-wide association study (GWAS) disease associations. Furthermore, allele-specific bias of TF binding could aid the functional elucidation of many non-coding SNPs that are associated with disease. 2 Many regulatory elements are located distally from the genes that they regulate, and using chromosome conformation capture carbon copy and chromosome interaction analysis by paired end tagging (ChIA-PET) methods, these long range interactions were assessed across 1% of the genome. Chromosomal folding was enriched at a distance of approximately 120 kb, and only 7% of interactions detected were with the nearest gene. In addition, multiple distal sites can come together to regulate one gene forming a regulatory cluster of chromatin.
EVOLUTION AND POPULATION GENETICS
Comparative genomics across mammalian species suggests that B5% of the human genome is conserved because of non-coding or regulatory regions. The ENCODE project was able to suggest that another 4% of the human genome is under lineage-specific purifying selection. Interestingly, these non-conserved yet constrained regions of the human genome are enriched for regions that are associated with retinal cone development and nerve growth, consistent with the rapid development of these pathways in humans. 4, 15, 16 Within DHSs are DNase footprints, depressions in the DNase signal that are indicative of DNA-bound proteins. These footprints are heavily enriched for TF sequence motifs, and de novo discovery of motifs from these footprints recovers 90% of motifs from the TF and microarray databases JASPAR, TRANSFAC and UNIPROBE. 17 Integration of variant data and genome-wide DHS maps showed that individuals harbour more regulatory variation than protein-coding variation, as a function of the greater sequence length of the former category. DHSs were compared across 92 different cell types, organised into three categories (normal/primary, pluripotent or malignant) and the core DHSs shared between two or more categories had a markedly reduced diversity compared with those present in one category alone, suggesting that DNA elements required for regulatory programs in multiple cell types are under stronger purifying selection than those present in only one cell type. As a measure of geographically restricted selection, population structure for variants within DHSs was computed between individuals of European, African and Asian ancestry. Genes near the DHSs that showed the most diversity between populations were examined for enrichment of functional classifications. The most enriched gene set in the European population were involved in melanogenesis, whereas two pathways unique to the African ancestry population were pathways for chemokine and adipocytokine signalling. 18 Some of the various data types generated by ENCODE have been integrated to database platform in the online resource RegulomeDB. This resource includes TF ChIP-seq data, histone ChIP-seq data, DNase-seq data and FAIRE-seq data as well as ChIPseq data in the from the NCBI sequence read archive totaling 962 experimental data sets and approximately 60 million annotations. 19 
INTEGRATION OF ENCODE DATA WITH GWAS DATA
The majority of genome-wide significant SNP-phenotype associations obtained from the NHGRI catalogue lie within regions of the genome that are not transcribed. Now ENCODE data can be used to define additional functional elements throughout the genome to allow further annotation of disease-associated SNPs (Figure 1 ). Of these disease-associated SNPs, 44.8% overlap with an ENCODE annotation and 58% were in strong linkage disequilibrium with a SNP in a functional element. Approximately one-fifth of associated SNPs in European populations were either an expression quantitative trait locus (eQTL), or were in strong linkage disequilibrium with a SNP that is suggested to be an eQTL. It is to be expected that further analysis of these findings will yield novel biological hypotheses. 20 Maurano et al.
3 demonstrated the systematic localisation of disease or trait-associated SNPs within regulatory DNA (DHSs). Over three quarters of SNPs investigated were in a DHS or were in perfect linkage disequilibrium with a DHS. Furthermore, SNPs associated with diseases were enriched in DHSs that were active only in pathologically relevant cells, for example, SNPs associated with neurological disorders were enriched in fetal brain, but not other cells types. Over 90% of associated SNPs in DHS overlap a TF recognition sequence and the diseases classes to which these SNPs are associated cluster with the binding motifs that were independently assigned to the same disease classes. Furthermore, SNPs associated with neurological disorder within motifs are enriched in regulatory or binding partner motifs of the TF OTX1, suggesting a common regulatory network that is disrupted across a range of neurological disorders. SNPs associated with several neurological disorders were found to be in DHSs that were correlated with distal genes that were also biologically plausible candidates for pathogenesis. SNPs associated with amyotrophic lateral sclerosis were correlated with SYNGAP1 and CNTN4 the annotated functions of which were axon formation, and neuronal cell adhesion. An attention deficit hyperactivity disorder-associated SNP lay within a DHS correlated with PDLIM5, which is involved in neuronal calcium signalling. KIF1A and FXR1, responsible for neuron-specific kinesin involved in axon transport, and cognitive function were correlated with DHSs containing SNPs associated with schizophrenia. None of these genes were adjacent to the associated SNPs and so would have previously been overlooked when interpreting GWAS results.
CONCLUSIONS
These early reports from ENCODE indicate how we can use the ENCODE data to identify and prioritise further research on the results of GWAS and genomic studies of wider range of variants (rare, intermediate, copy number variation, methylation and so on).
The ENCODE project has produced an enormous amount of data that will aide functional annotation of SNPs associated with diseases as well as provide a wealth of information on how particular gene sets are regulated in a cell-specific manner, identify new TFs and detail how distal regulatory elements interact and influence their cognate promoter. However, it is important to note that many more cell types need to be investigated and that much of the ENCODE data comes from cells that are not neurologically relevant. In fact, there are only two tier 2 neural cell lines, H1-neurons derived from embryonic stem cells, and a neuroblastoma cell line. As these cell lines were only promoted to tier 2 after the January 2011 data freeze the current set of ENCODE publications do not report as much data from these cells as from some of the other cell lines. As ENCODE moves to the production phase and begins to apply these technologies and analyses to the wider range of cells a vast amount of data will be produced, dwarfing what is presently available. In addition, it has demonstrated the use of several key methodologies that can now be used by many other groups to address more specific problems, which will aide gene discovery efforts, functional studies and novel therapeutics. Figure 1 . Annotation of disease-associated variants from ENCyclopedia Of DNA Elements (ENCODE) data. It is often assumed that diseaseassociated single-nucleotide polymorphisms (SNPs) are functionally related to the nearest gene. As shown above, these SNPs can lie within ENCODE regions or be in strong linkage disequilibrium with SNPs in ENCODE regions. Regions of open chromatin as identified by sensitivity to DNase I are indicative of regulatory DNA. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) peaks are often found within DNase hypersensitivity (DHS) footprints, regions within DHSs of reduced DNase I sensitivity signal. Variants within transcription factor-binding sites (TFBS) may alter the binding and function of those TFs. Distal elements can be brought into proximity to affect gene function through long range chromosomal interaction. ENCODE data such as these can be used to identify how non-coding variants associated with disease may be functional and implicate new genes in disease pathogenesis.
